Myomo (MYO) Projected to Post Earnings on Wednesday

by · The Cerbat Gem

Myomo (NYSEAMERICAN:MYO – Get Free Report) will likely be issuing its Q1 2025 quarterly earnings data after the market closes on Wednesday, May 7th. Analysts expect Myomo to post earnings of ($0.08) per share and revenue of $9.22 million for the quarter.

Myomo Stock Performance

Shares of NYSEAMERICAN:MYO traded down $0.09 during trading on Monday, hitting $4.79. 99,227 shares of the stock were exchanged, compared to its average volume of 348,128. The company has a fifty day simple moving average of $4.85. The company has a market capitalization of $144.90 million, a P/E ratio of -20.74 and a beta of 1.68. Myomo has a 12-month low of $2.76 and a 12-month high of $7.17.

Analysts Set New Price Targets

Several equities analysts have weighed in on the company. Ascendiant Capital Markets raised their price target on Myomo from $9.00 to $11.00 and gave the stock a “buy” rating in a research report on Monday, March 17th. Alliance Global Partners restated a “buy” rating on shares of Myomo in a report on Tuesday, March 11th. HC Wainwright raised their price target on shares of Myomo from $7.50 to $9.50 and gave the company a “buy” rating in a report on Wednesday, March 12th. Finally, Craig Hallum upped their target price on Myomo from $9.00 to $11.00 and gave the stock a “buy” rating in a research report on Tuesday, March 11th. Five research analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average price target of $9.75.

View Our Latest Stock Analysis on MYO

Insider Activity at Myomo

In related news, insider Micah Mitchell sold 48,000 shares of the firm’s stock in a transaction on Friday, March 14th. The shares were sold at an average price of $5.16, for a total value of $247,680.00. Following the transaction, the insider now directly owns 140,572 shares in the company, valued at approximately $725,351.52. This trade represents a 25.45 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, insider Harry Kovelman sold 30,000 shares of the firm’s stock in a transaction dated Wednesday, March 12th. The shares were sold at an average price of $5.50, for a total value of $165,000.00. Following the completion of the sale, the insider now directly owns 97,973 shares in the company, valued at approximately $538,851.50. This represents a 23.44 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 4.54% of the stock is owned by insiders.

Myomo Company Profile

(Get Free Report)

Myomo, Inc, a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient’s weak or paralyzed arm to enable and improve functional activities of daily living.

Read More